Avanos Corp (AVNS): Price-to-Revenue Coefficient

Symbol and logo of brand Avanos (AVNS)

Growth for Avanos Medical, Inc. (AVNS) is constrained by pricing pressure from insurers and the risk of litigation. The price-to-sales ratio, as seen on the GURU.Markets chart, demonstrates valuation volatility, where 1.60 captures a new level. This confirms the status of a reliable provider of nutrition and pain management systems, whose operational efficiency is supported by perfectly streamlined component logistics and warehouse diversification.

AVNS: Avanos Medical Price-to-Revenue Ratio 07/04/2022 - 08/08/2026

Analytical breakdowns for Avanos Medical (AVNS)

- stock value and consensus price forecast:
General company analysis:AVNS, Avanos Medical
Mass-produced product of avanos.com

High barriers to entry in the medical consumables sector provide Avanos Medical, Inc. (AVNS) with stable demand due to FDA certification and integration into hospital networks. By analyzing the price-to-sales ratio dynamics, an investor assesses current market capitalization relative to annual revenue, which allows for the identification of asset undervaluation and confirms the fundamental stability of the business through market consensus.